149 related articles for article (PubMed ID: 38459202)
21. Predictors of 30-day and 1-year mortality after transvenous lead extraction: a single-centre experience.
Deckx S; Marynissen T; Rega F; Ector J; Nuyens D; Heidbuchel H; Willems R
Europace; 2014 Aug; 16(8):1218-25. PubMed ID: 24569572
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival.
Tarakji KG; Wazni OM; Harb S; Hsu A; Saliba W; Wilkoff BL
Europace; 2014 Oct; 16(10):1490-5. PubMed ID: 25087154
[TBL] [Abstract][Full Text] [Related]
23. Discontinuation of cardiac implantable electronic device therapy after transvenous lead extraction.
Kutarski A; Jacheć W; Kosior J; Stec S; Nowosielecka D; Polewczyk A
Kardiol Pol; 2023; 81(11):1113-1121. PubMed ID: 37937353
[TBL] [Abstract][Full Text] [Related]
24. Presence of 'ghosts' and mortality after transvenous lead extraction.
Narducci ML; Di Monaco A; Pelargonio G; Leoncini E; Boccia S; Mollo R; Perna F; Bencardino G; Pennestrì F; Scoppettuolo G; Rebuzzi AG; Santangeli P; Di Biase L; Natale A; Crea F
Europace; 2017 Mar; 19(3):432-440. PubMed ID: 27025772
[TBL] [Abstract][Full Text] [Related]
25. Comparison of outcomes in infected cardiovascular implantable electronic devices between complete, partial, and failed lead removal: an ESC-EHRA-EORP ELECTRa (European Lead Extraction ConTrolled) registry.
Nof E; Bongiorni MG; Auricchio A; Butter C; Dagres N; Deharo JC; Rinaldi CA; Maggioni AP; Kutarski A; Kennergren C; Laroche C; Milman A; Beinart R; Bogdan S; Mortsell D; Calvi V; Desiron Q; Mansourati J; Blomstrom Lundqvist C; Glikson M;
Europace; 2019 Dec; 21(12):1876-1889. PubMed ID: 31625553
[TBL] [Abstract][Full Text] [Related]
26. Hybrid transvenous lead extraction during cardiac surgery for valvular endocarditis.
Yildirim Y; Petersen J; Tönnis T; Reichenspurner H; Pecha S
J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2101-2106. PubMed ID: 32478463
[TBL] [Abstract][Full Text] [Related]
27. Transvenous Lead Extraction in Chronic Kidney Disease and Dialysis Patients With Infected Cardiac Devices.
Barakat AF; Wazni OM; Tarakji KG; Callahan T; Nimri N; Saliba WI; Shah S; Abdur Rehman K; Rickard J; Brunner MP; Martin DO; Kanj M; Baranowski B; Cantillon D; Niebauer M; Dresing T; Lindsay BD; Wilkoff BL; Hussein AA
Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005706. PubMed ID: 29321192
[TBL] [Abstract][Full Text] [Related]
28. Safety and In-Hospital Outcomes of Transvenous Lead Extraction for Cardiac Implantable Device-Related Infections: Analysis of 13 Years of Inpatient Data in the United States.
Hosseini SM; Rozen G; Kaadan MI; Galvin J; Ruskin JN
JACC Clin Electrophysiol; 2019 Dec; 5(12):1450-1458. PubMed ID: 31857046
[TBL] [Abstract][Full Text] [Related]
29. Trends in Use and Adverse Outcomes Associated with Transvenous Lead Removal in the United States.
Deshmukh A; Patel N; Noseworthy PA; Patel AA; Patel N; Arora S; Kapa S; Noheria A; Mulpuru S; Badheka A; Fischer A; Coffey JO; Cha YM; Friedman P; Asirvatham S; Viles-Gonzalez JF
Circulation; 2015 Dec; 132(25):2363-71. PubMed ID: 26534954
[TBL] [Abstract][Full Text] [Related]
30. Incidence and risk factors for acute kidney injury in patients with cardiac implantable electronic devices undergoing transvenous lead removal.
Edlinger C; Bannehr M; Haj-Kheder S; Möller V; Georgi C; Reiners D; Dworok V; Haase-Fielitz A; Butter C
Clin Nephrol; 2022 Jun; 97(6):321-327. PubMed ID: 35072621
[TBL] [Abstract][Full Text] [Related]
31. Impact of delayed device re-implantation on outcomes of patients with cardiovascular implantable electronic device related infective endocarditis.
Arshad V; Baddour LM; Lahr BD; Khalil S; Tariq W; Talha KM; Cha YM; DeSimone DC; Sohail MR
Pacing Clin Electrophysiol; 2021 Aug; 44(8):1303-1311. PubMed ID: 34132396
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcomes following transvenous lead extraction: Data from a tertiary referral center.
Arabia G; Mitacchione G; Cersosimo A; Calvi E; Salghetti F; Bontempi L; Giacopelli D; Cerini M; Curnis A
Int J Cardiol; 2023 May; 378():32-38. PubMed ID: 36841289
[TBL] [Abstract][Full Text] [Related]
33. Lead-Related Infective Endocarditis in Latvia: A Single Centre Experience.
Nesterovics N; Nesterovics G; Stradins P; Kalejs M; Ansabergs J; Blumbergs M; Maca A; Kamzola G; Lejnieks A; Kalejs O; Erglis A
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31484433
[No Abstract] [Full Text] [Related]
34. Early, Delayed and Late Cardiac Implantable Electronic Device Infections: Do the Timing of Onset and Pathogens Matter?
Polewczyk A; Jacheć W; Polewczyk M; Szczęśniak-Stańczyk D; Kutarski A
J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887692
[TBL] [Abstract][Full Text] [Related]
35. Procedural outcome & risk prediction in young patients undergoing transvenous lead extraction-a GALLERY subgroup analysis.
Rexha E; Chung DU; Burger H; Ghaffari N; Madej T; Ziaukas V; Hassan K; Reichenspurner H; Gessler N; Willems S; Butter C; Pecha S; Hakmi S
Front Cardiovasc Med; 2023; 10():1251055. PubMed ID: 37745113
[TBL] [Abstract][Full Text] [Related]
36. Reimplantation and long-term mortality after transvenous lead extraction in a high-risk, single-center cohort.
Zsigmond EJ; Miklos M; Vida A; Benak A; Makai A; Schvartz N; Klausz G; Hegedus Z; Bogats G; Saghy L; Vamos M
J Interv Card Electrophysiol; 2023 Jun; 66(4):847-855. PubMed ID: 33723694
[TBL] [Abstract][Full Text] [Related]
37. Transvenous lead extraction in patients with cardiac resynchronization therapy devices is not associated with increased 30-day mortality.
Gould J; Klis M; Porter B; Sieniewicz BJ; Sidhu BS; Claridge S; Williams SE; Shetty A; O'Neill M; Gill J; Rinaldi CA
Europace; 2019 Jun; 21(6):928-936. PubMed ID: 30590509
[TBL] [Abstract][Full Text] [Related]
38. Experience of cardiac implantable electronic device lead removal from a South African tertiary referral centre.
Mkoko P; Mdakane NX; Govender G; Scherman J; Chin A
Cardiovasc J Afr; 2021 Jul-Aug 23; 32(4):193-197. PubMed ID: 33950067
[TBL] [Abstract][Full Text] [Related]
39. Transvenous lead extraction of implantable cardioverter-defibrillators: A comprehensive outcome-and risk factor analysis.
Chung DU; Burger H; Kaiser L; Osswald B; Bärsch V; Nägele H; Knaut M; Reichenspurner H; Gessler N; Willems S; Butter C; Pecha S; Hakmi S;
Pacing Clin Electrophysiol; 2023 Aug; 46(8):815-823. PubMed ID: 37461858
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of cardiac implantable electronic device transvenous lead extractions performed in centers without onsite cardiac surgery.
Mohamed MO; Greenspon A; Contractor T; Rashid M; Kwok CS; Potts J; Barker D; Patwala A; Mamas MA
Int J Cardiol; 2020 Feb; 300():154-160. PubMed ID: 31402163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
